Biopharma

Pharmacology and the development of novel therapeutics is an important part of keeping people healthy and long living. From treating basic ailments like scrapes and bruises, to tackling complex cancers and rare diseases, the importance of this industry can’t be overstated. However, creating an ideal therapeutic is not a strait forward process. An illness must…

Drug development is a long and complicated process that involves several types of analytical instruments used in a variety of ways and purposes. Starting at early discovery, a targeted process occurs during drug and biomarker discovery to identifying a drug candidate. These drug candidates are then tested in preclinical and clinical trials, translational research, and…

Using the right laboratory instrumentation at the right time is crucial to the process of drug discovery and development. Life science and analytical instrumentation facilitates R&D involving in a wide variety of workflows throughout early discovery, biomarker identification, clinical trials, translational research, and quality control testing throughout the development of new therapeutic products. The inherent need…

Outsourcing drug discovery represents the initial phase of the drug development process. By outsourcing segments of their drug discovery programs, pharmaceutical and biotechnology companies have discovered a cost-effective strategy that enhances hit-to-lead conversion and early identification of ineffective compounds. Outsourcing accelerates the drug discovery process, transforming the industry from low-end research services to high-value, sophisticated…

The global demand for biopharmaceuticals is expanding at a rapid pace, as they are more extensively accepted for the clinical treatment of a wide range of ailments. Unlike small molecule drugs, these biomolecule-based therapeutics, or biologics, are produced using living cells in two distinct phases, called upstream and downstream, which necessitates unique manufacturing processes collectively…

The pharma/bio sector is one of the highest growing markets in the world, driven by innovations that aim to provide better medication and healthcare for mankind. The development and production of these therapeutics is a costly and lengthy process which is highly regulated at all steps. With significant investments required for R&D, manufacturing, and quality…

Non-alcoholic steatohepatitis (NASH) is a serious liver disease characterized by inflammation and liver cell damage, which can lead to cirrhosis. Despite the absence of approved medications specifically for NASH, there are nearly 80 drug candidates in development. Kalorama Information’s report, NASH Drug Pipeline and Market Overview, provides an in-depth analysis of these drug candidates, including…

CAR-T Cell Therapy Market Review provides an insightful examination of CAR-T therapy, a revolutionary form of immunotherapy harnessing the body’s T cells to target and eradicate cancer cells. This report delves into the technology behind CAR-T, its application in treating diseases like acute lymphoblastic leukemia, DLBCL B-cell lymphomas, and multiple myeloma.

Key Objectives and Questions…

Laboratory instrumentation is ubiquitous throughout all stages of drug development, aiding scientists involved in a wide variety of workflows, including drug discovery, clinical trials, translational research, and the quality control testing of input materials and finished products. The inherent need for precise and accurate data on pharmaceutical and biotherapeutic compounds throughout their development, combined with the…

Biosimilar Market Trends, 2019 offers insights into the dynamic landscape of biosimilar markets worldwide. This comprehensive report delves into the strategies employed by both innovator and generic companies, providing a snapshot of key trends and issues influencing the biosimilar industry. With coverage spanning biopharmaceuticals, the report examines regulatory environments, market opportunities, and challenges, offering invaluable…